Fund+
People
7
Locations
1
Publications
18
Company Profile
Founded Date
May 7, 2015
Last Balance Sheet Year
2024
Juridical Form
Naamloze vennootschap
Enterprise Type
Rechtspersoon
Activity
64310 - Activiteiten van geldmarkt- en niet-geldmarktbeleggingsfondsen
Company Age
11 years
Contact Details
Unlock direct contact points, registry address detail, and website links for Fund+.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorical Financials
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | €1,695 | - | - |
| Gross Margin | -€1,927,170 (+29.6%) | -€2,735,814 (-18.2%) | -€2,315,201 (+10.0%) |
| Profit | €2,289,239 (-86.7%) | €17,178,847 (+501.4%) | -€4,280,052 (-120.0%) |
| EBITDA | €2,293,043 (-86.7%) | €17,190,875 (+489.3%) | -€4,415,565 (-120.5%) |
| Equity | €121,274,995 (+1.9%) | €118,985,756 (-0.5%) | €119,593,001 (-3.5%) |
| Debt | €1,708,927 (-93.0%) | €24,541,612 (+9908.5%) | €245,208 (-95.7%) |
| Total Assets | €123,011,267 (-14.3%) | €143,527,368 (+19.8%) | €119,838,209 (-7.5%) |
| Cash | €8,258,827 (+401.9%) | €1,645,536 (+142.5%) | €678,459 (-15.6%) |
| FTE | 0.9 (-43.8%) | 1.6 (+23.1%) | 1.3 (+85.7%) |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for Fund+.
Create Free AccountFinancial Health
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
18.9x
(+1072.9%)
Quick Ratio
18.9x
(+1072.9%)
Solvency
98.6%
(+18.9%)
Debt / Equity
0.0x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountLocations & Footprint
Establishment
AddressGroot Begijnhof 60 b1, 3000 Leuven, Belgium
Entity Network
First-level relations linked directly to Fund+. Unlock second-level relations for deeper graph exploration.
Fund+
Active
- Aelin Therapeutics
Outgoing link
Administrator Legal - DR. IR. U. VANDEURZEN MANAGEMENT FIRM
Incoming link
Administrator Legal - EYED PHARMA
Outgoing link
Administrator Legal - LGP Advisory
Incoming link
Administrator Legal - MULTIFIN
Incoming link
Administrator Legal - UniD Manufacturing
Outgoing link
Administrator Legal -
Chris Buyse
Incoming link
Administrator Natural -
Debasish Roychowdhury
Incoming link
Administrator Natural -
François FONTAINE
Incoming link
Administrator Natural -
Luc Debruyne
Incoming link
Administrator Natural -
MARK WAER
Incoming link
Administrator Natural - Aelin Therapeutics
Incoming link
Participating Interest - AstriVax Therapeutics
Incoming link
Participating Interest - Cellaïon
Incoming link
Participating Interest - Confo Therapeutics
Incoming link
Participating Interest - EPICS THERAPEUTICS
Incoming link
Participating Interest - ETHERNA IMMUNOTHERAPIES
Incoming link
Participating Interest - ExeVir Bio
Incoming link
Participating Interest - EYED PHARMA
Incoming link
Participating Interest - FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ
Outgoing link
Participating Interest - Indigo Diabetes
Incoming link
Participating Interest - MULTIFIN
Outgoing link
Participating Interest - NOVADIP BIOSCIENCES
Incoming link
Participating Interest - OCTIMET Oncology
Incoming link
Participating Interest - UniD Manufacturing
Incoming link
Participating Interest - VF Capital
Outgoing link
Participating Interest - Aelin Therapeutics
Outgoing link
Shareholder Entity - Confo Therapeutics
Outgoing link
Shareholder Entity -
Chris Buyse
Incoming link
Administrator Legal Representative -
Gerard Lamarche
Incoming link
Administrator Legal Representative -
Luc Debruyne
Incoming link
Administrator Legal Representative -
Urbanus Vandeurzen
Incoming link
Administrator Legal Representative
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpManagement & Key People
Unlock linked people, governance roles, and enriched demographic signals associated with Fund+.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account